Poster Session 3


Matías Blaustein

iB3-DFBMC-FCEyN-UBA and CONICET, Buenos Aires, Argentina

Germán Gil

CIQUIBIC CONICET, Universidad Nacional de Córdoba, Córdoba, Argentina.

  1. PS3-36. Role of Thyroid Hormones in breast cancer resistance to chemotherapy
  2. PS3-37. ACE2 downregulation as a resistance mechanism to VEGFR-tyrosine kinase inhibitor (VEGFR-TKI) treatment in breast cancer therapy
  3. PS3-38. Cytokinesis inhibition induces synthetic lethality and mitotic abnormalities in BRCA2-deficient cell lines
  4. PS3-39. Emerging role of AhR / c-Src signaling in breast cancer cell migration induced by tumor acidosis
  5. PS3-40. Soluble tumor necrosis factor alpha fosters tumor growth, innate immune evasion and resistance to lapatinib in HER2-positive breast cancer
  6. PS3-41. Effect of Lapatinib and All-Trans Retinoic Acid (ATRA) combined treatment on mammary cancer stem cells derived from HER2 negative cell lines
  7. PS3-42. Influence of Structural Variants of the TRIC-CCT complex´s genes on patient survival and the main molecular pathways related to breast cancer
  8. PS3-43. In silico identification of ADRA2A-associated miRNA expression as biomarkers for disease-free survival in breast cancer subtypes
  9. PS3-44. Integrative single-cell transcriptomic analysis unveils alternative polyadenylation modulation in the mouse mammary gland
  10. PS3-45. Differentiation of 3T3-L1 preadipocytes into beige adipocytes regulate mammary tumor cells behavior
  11. PS3-46. Soluble factors from the tumor-adipocyte interplay stimulate morphological and metabolic changes in 3T3-L1 adipocytes
  12. PS3-47. The Kinin B1 Receptor induces the expression and secretion of IL-10 and M-CSF from breast cancer cells, favoring the differentiation and migration of macrophages
  13. PS3-48. Low-grade inflammation is related to KLK3 levels in breast cancer
  14. PS3-49. Identification of circulating miRNAs associated to Kaiso and triple negative breast cancer in mice model
  15. PS3-50. Potential use of PI3K pathway effectors and associated microRNAs as biomarkers of breast cancer prognosis
  16. PS3-51. Glycerol-3P-Acyltransferase 2 expression in MDA-MB-231 cells modulates the expression of Long Non-Coding RNAs linked to survival prediction in breast cancer patients
  17. PS3-52. Establishing histopathological criteria for breast cancer research
  18. PS1-04. Analysis of Akt molecular, subcellular and tumoral code as an explanatory and predictive tool for the effectiveness of therapies against breast cancer